The Mitsubishi Tanabe Pharma Group engages Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) across Europe.
We are committed to ensuring transparency in our interaction with HCPs and HCOs. In accordance with the EFPIA Code of Transfers of Value from Pharmaceutical Companies 2014, details of Transfers of Value made to HCPs and HCOs in Europe by the Mitsubishi Tanabe Pharma Group can be found below.
The Methodology applied in preparing and collating these figures is available here in English*, French* and German*.
If you are a Healthcare Professional and have any questions regarding the figures disclosed, please contact:
Finance@mt-pharma-eu.com.
2020 Transfers of Value
| Austria | |
|---|---|
| Research & Development | EUR 27,567.52 |
| Non-Research & Development | EUR 39,013.10 |
| Full details here | |
| Belgium | |
|---|---|
| Research & Development | EUR 41,677.50 |
| Non-Research & Development | EUR 7,500.00 |
| Full details here | |
| Bulgaria | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Croatia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Cyprus | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Czech Republic | |
|---|---|
| Research & Development | EUR 4,536.23 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Denmark | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Estonia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Finland | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| France | |
|---|---|
| Research & Development | EUR 441,861.75 |
| Non-Research & Development | EUR 5,000.00 |
| Full details here | |
| Germany | |
|---|---|
| Research & Development | EUR 39,402.76 |
| Non-Research & Development | EUR 81,295.45 |
| Full details here | |
| Greece | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Hungary | |
|---|---|
| Research & Development | HUF 430,000.00 |
| Non-Research & Development | HUF 0.00 |
| Full details here | |
| Ireland | |
|---|---|
| Research & Development | EUR 193,699.64 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Italy | |
|---|---|
| Research & Development | EUR 89,773.40 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Latvia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Lithuania | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Malta | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| The Netherlands | |
|---|---|
| Research & Development | EUR 173,296.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Norway | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Poland | |
|---|---|
| Research & Development | EUR 50,792.89 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Portugal | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Romania | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Russia | |
|---|---|
| Research & Development | EUR 5,716.46 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Serbia | |
|---|---|
| Research & Development | RSD 1,643,600.00 |
| Non-Research & Development | RSD 0.00 |
| Full details here | |
| Slovakia | |
|---|---|
| Research & Development | EUR 3,877.50 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Slovenia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Spain | |
|---|---|
| Research & Development | EUR 17,238.30 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Sweden | |
|---|---|
| Research & Development | SEK 180,900.00 |
| Non-Research & Development | SEK 0.00 |
| Full details here | |
| Switzerland | |
|---|---|
| Research & Development | CHF 56,243.20 |
| Non-Research & Development | CHF 50,592.82 |
| Full details here | |
| Turkey | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Ukraine | |
|---|---|
| Research & Development | UAH 17,250.00 |
| Non-Research & Development | UAH 0.00 |
| Full details here | |
| United Kingdom | |
|---|---|
| Research & Development | GBP 24,302.95 |
| Non-Research & Development | GBP 36,266.67 |
| Full details here or here (ABPI Website) | |
* The Mitsubishi Tanabe Pharma Group has established legal entities in the United Kingdom, Germany and Switzerland and therefore disclosure is made according to local requirements for these countries
Terms and Privacy
Contact Us
Mitsubishi TANABE Pharma Europe Ltd
Dashwood House
69 Old Broad Street
London
EC2M 1QS
United Kingdom